Promising Results For Glivec In CML Continue, FDA Grants Priority Review
High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I
Wilms’ Tumor Survivors At High Risk Of Heart Failure
Cancer Pain Treatment Guide Published By NCCN, ACS
Without Advance Directives, Families Prolong Treatment
Long-Term Estrogen Use May Increase Ovarian Cancer Risk
Natural Substance Blocks Androgen Activity In Vitro
NCI-Approved Clinical Trials Listed For Month Of March
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - Oncologist Rachna Shroff endows award to outlast her cancer diagnosis
“Because of my health, I have a profound desire to see this endowment come to fruition now” - KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Anthony Letai reflects on Year One as NCI Director: “The NCI is in business”
